Fathom Nickel Inc
OTC:FNICF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fathom Nickel Inc
OTC:FNICF
|
CA |
|
American Healthcare REIT Inc
NYSE:AHRT
|
US |
|
Appili Therapeutics Inc
TSX:APLI
|
CA |
|
Delivra Health Brands Inc
OTC:DHBUD
|
CA |
|
Vsee Health Inc
NASDAQ:VSEE
|
US |
Income Statement
Earnings Waterfall
Fathom Nickel Inc
Income Statement
Fathom Nickel Inc
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(1)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(0)
|
1
|
1
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(1)
N/A
|
(2)
-73%
|
(1)
+73%
|
(1)
-21%
|
(1)
-16%
|
(1)
-50%
|
(2)
-57%
|
(2)
-11%
|
(2)
+11%
|
(2)
-16%
|
(2)
+9%
|
(2)
+15%
|
(1)
+9%
|
(1)
+31%
|
(1)
+27%
|
(1)
-32%
|
(1)
+9%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(5)
-22%
|
(1)
+88%
|
(1)
-21%
|
(1)
-16%
|
(1)
-50%
|
(2)
-58%
|
(2)
-12%
|
(2)
+11%
|
(2)
-13%
|
(2)
+8%
|
(2)
+16%
|
(1)
+9%
|
(1)
+30%
|
(1)
+26%
|
(1)
-33%
|
(1)
+9%
|
|
| Net Income | ||||||||||||||||||
| Income from Continuing Operations |
(4)
|
(5)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Net Income (Common) |
(4)
N/A
|
(5)
-22%
|
(1)
+88%
|
(1)
-21%
|
(1)
-16%
|
(1)
-50%
|
(2)
-58%
|
(2)
-12%
|
(2)
+11%
|
(2)
-13%
|
(2)
+8%
|
(2)
+16%
|
(1)
+9%
|
(1)
+30%
|
(1)
+26%
|
(1)
-33%
|
(1)
+9%
|
|
| EPS (Diluted) |
-0.09
N/A
|
-0.12
-33%
|
-0.01
+92%
|
-0.02
-100%
|
-0.02
N/A
|
-0.02
N/A
|
-0.03
-50%
|
-0.03
N/A
|
-0.02
+33%
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|